imipenem + meropenem + piperacillin + tazobactam

This is a combination of four antibiotics—imipenem, meropenem, piperacillin, and tazobactam. Imipenem and meropenem are carbapenem-class beta-lactam antibiotics with broad-spectrum activity against Gram-positive and Gram-negative bacteria, including many multidrug-resistant organisms. Piperacillin is an extended-spectrum ureidopenicillin antibiotic that is commonly combined with tazobactam, a beta-lactamase inhibitor that protects piperacillin from enzymatic degradation by beta-lactamase-producing bacteria. The combination of these agents would theoretically provide extremely broad antibacterial coverage—including most aerobic and anaerobic Gram-positive and Gram-negative pathogens—and strong protection against organisms producing various classes of beta-lactamases[1][2][3][5]. Each component acts by inhibiting bacterial cell wall synthesis (imipenem, meropenem, piperacillin), while tazobactam inhibits bacterial beta-lactamases to prevent inactivation of the penicillin derivative[5]. This specific four-drug combination does not correspond to any approved or marketed product; it represents an unusual regimen likely considered only in extreme cases involving highly resistant infections.